Value Add VC tracks 1 company Novartis has invested in and 1 venture round it took part in (0 as lead).
Novartis key facts (as of )
| Fact | Value | Source |
|---|---|---|
| Type | Venture capital firm | Value Add VC classification |
| Venture rounds tracked | 1 (led 0, joined 1) 1 in the last 12 months | Recent deals table on this page (each round cites its source) |
| Portfolio companies tracked | 1 | Portfolio list on this page |
Recent deals we track
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Flare Therapeutics | Series C | Participated | $85M | — | Pulse story |
Is something wrong on this page?
We track Novartis but have little verified detail yet.
Portfolio
1 totalCo-Investors
6Novartis FAQ
What stage does Novartis invest at?
In the rounds Value Add VC tracks, Novartis' deals were most often Series C (1).
What companies has Novartis backed?
Companies Value Add VC tracks as Novartis investments include Flare Therapeutics.
Who does Novartis co-invest with most?
In the rounds Value Add tracks, Novartis most often invests alongside Casdin Capital (1 shared deal), Eli Lilly (1 shared deal), Eli Lilly and Company (1 shared deal), Invus (1 shared deal), Nextech Invest (1 shared deal).
Sources & methodologyshow
- GlobeNewswireprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.